Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sipuleucel-T in non-metastatic prostate cancer
NCT00779402Phase 3Completed
- Sponsor
- Dendreon
- Start
- Oct 2001
- Primary completion
- Aug 2006
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of sipuleucel-T in prostate cancer (PCa), sponsored by Dendreon. Started Oct 2001; status: completed.
02
Drugs
sipuleucel-T
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00779402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779402.